English
简体中文
Total: £ 56.28
Published Date: 2025-06-13 | Pages: 166 | Tables: 169 | Medical Care
In 2024, the global market size of Competent Cells was estimated to be worth US$ 2382 million and is forecast to reach approximately US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent Cells.
The Competent Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Competent Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid Creation
Cre-Lox Recombination (PIR1/PIR2)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Competent Cells in global and regional level.
Chapter 3: Detailed analysis of Competent Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Competent Cells revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Competent Cells Product Introduction
1.2 Market by Type
1.2.1 Global Competent Cells Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Competent Cells Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Competent Cells Market Size Estimates and Forecasts
2.2 Competent Cells Market Size by Region: 2024 Versus 2031
2.2.1 Global Competent Cells Revenue by Region: 2020-2025
2.2.2 Global Competent Cells Revenue Forecast by Region (2026-2031)
2.2.3 Global Competent Cells Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Competent Cells Revenue by Type (2020-2031)
3.1.2 Global Competent Cells Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Competent Cells Revenue by Application (2020-2031)
3.2.2 Global Competent Cells Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Chemically Competent Cells of Competent Cells Revenue Market Share by Application
3.3.2 Electrocompetent Cells of Competent Cells Revenue Market Share by Application
4 Global Competent Cells by Company
4.1 Global Competent Cells Revenue by Company (2020-2025)
4.2 Global Competent Cells Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Competent Cells Companies around the World: Ranking by Revenue
4.3.2 Global Competent Cells Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Competent Cells Companies Headquarters & Product Type
4.4.1 Global Competent Cells Companies Headquarters
4.4.2 Date of International Companies Enter into Competent Cells Market
4.4.3 Global Competent Cells Companies Product & Service
4.4.4 Chemically Competent Cells Revenue Market Share of Competent Cells by Company
4.4.5 Electrocompetent Cells Revenue Market Share of Competent Cells by Company
4.5 Global Competent Cells Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck KGaA
5.1.1 Merck KGaA Corporation Information
5.1.2 Merck KGaA Description, Business Overview
5.1.3 Merck KGaA Competent Cells Products Offered
5.1.4 Merck KGaA Competent Cells Revenue and Gross Margin (2020-2025)
5.1.5 Merck KGaA Competent Cells Revenue by Product in 2024
5.1.6 Merck KGaA Competent Cells Revenue by Application in 2024
5.1.7 Merck KGaA Competent Cells Revenue by Geographic Area in 2024
5.1.8 Merck KGaA Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Corporation Information
5.2.2 Thermo Fisher Scientific Description, Business Overview
5.2.3 Thermo Fisher Scientific Competent Cells Products Offered
5.2.4 Thermo Fisher Scientific Competent Cells Revenue and Gross Margin (2020-2025)
5.2.5 Thermo Fisher Scientific Competent Cells Revenue by Product in 2024
5.2.6 Thermo Fisher Scientific Competent Cells Revenue by Application in 2024
5.2.7 Thermo Fisher Scientific Competent Cells Revenue by Geographic Area in 2024
5.2.8 Thermo Fisher Scientific Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Corporation Information
5.3.2 Agilent Technologies Description, Business Overview
5.3.3 Agilent Technologies Competent Cells Products Offered
5.3.4 Agilent Technologies Competent Cells Revenue and Gross Margin (2020-2025)
5.3.5 Agilent Technologies Competent Cells Revenue by Product in 2024
5.3.6 Agilent Technologies Competent Cells Revenue by Application in 2024
5.3.7 Agilent Technologies Competent Cells Revenue by Geographic Area in 2024
5.3.8 Agilent Technologies Recent Developments
5.4 Takara Bio
5.4.1 Takara Bio Corporation Information
5.4.2 Takara Bio Description, Business Overview
5.4.3 Takara Bio Competent Cells Products Offered
5.4.4 Takara Bio Competent Cells Revenue and Gross Margin (2020-2025)
5.4.5 Takara Bio Competent Cells Revenue by Product in 2024
5.4.6 Takara Bio Competent Cells Revenue by Application in 2024
5.4.7 Takara Bio Competent Cells Revenue by Geographic Area in 2024
5.4.8 Takara Bio Recent Developments
5.5 Promega Corporation
5.5.1 Promega Corporation Corporation Information
5.5.2 Promega Corporation Description, Business Overview
5.5.3 Promega Corporation Competent Cells Products Offered
5.5.4 Promega Corporation Competent Cells Revenue and Gross Margin (2020-2025)
5.5.5 Promega Corporation Competent Cells Revenue by Product in 2024
5.5.6 Promega Corporation Competent Cells Revenue by Application in 2024
5.5.7 Promega Corporation Competent Cells Revenue by Geographic Area in 2024
5.5.8 Promega Corporation Recent Developments
5.6 Beijing TransGen Biotech
5.6.1 Beijing TransGen Biotech Corporation Information
5.6.2 Beijing TransGen Biotech Description, Business Overview
5.6.3 Beijing TransGen Biotech Competent Cells Products Offered
5.6.4 Beijing TransGen Biotech Competent Cells Revenue and Gross Margin (2020-2025)
5.6.5 Beijing TransGen Biotech Competent Cells Revenue by Product in 2024
5.6.6 Beijing TransGen Biotech Competent Cells Revenue by Application in 2024
5.6.7 Beijing TransGen Biotech Competent Cells Revenue by Geographic Area in 2024
5.6.8 Beijing TransGen Biotech Recent Developments
5.7 GeneScript Corporation
5.7.1 GeneScript Corporation Corporation Information
5.7.2 GeneScript Corporation Description, Business Overview
5.7.3 GeneScript Corporation Competent Cells Products Offered
5.7.4 GeneScript Corporation Competent Cells Revenue and Gross Margin (2020-2025)
5.7.5 GeneScript Corporation Competent Cells Revenue by Product in 2024
5.7.6 GeneScript Corporation Competent Cells Revenue by Application in 2024
5.7.7 GeneScript Corporation Competent Cells Revenue by Geographic Area in 2024
5.7.8 GeneScript Corporation Recent Developments
5.8 Yeastern Biotech
5.8.1 Yeastern Biotech Corporation Information
5.8.2 Yeastern Biotech Description, Business Overview
5.8.3 Yeastern Biotech Competent Cells Products Offered
5.8.4 Yeastern Biotech Competent Cells Revenue and Gross Margin (2020-2025)
5.8.5 Yeastern Biotech Competent Cells Revenue by Product in 2024
5.8.6 Yeastern Biotech Competent Cells Revenue by Application in 2024
5.8.7 Yeastern Biotech Competent Cells Revenue by Geographic Area in 2024
5.8.8 Yeastern Biotech Recent Developments
5.9 New England Biolabs
5.9.1 New England Biolabs Corporation Information
5.9.2 New England Biolabs Description, Business Overview
5.9.3 New England Biolabs Competent Cells Products Offered
5.9.4 New England Biolabs Competent Cells Revenue and Gross Margin (2020-2025)
5.9.5 New England Biolabs Competent Cells Revenue by Product in 2024
5.9.6 New England Biolabs Competent Cells Revenue by Application in 2024
5.9.7 New England Biolabs Competent Cells Revenue by Geographic Area in 2024
5.9.8 New England Biolabs Recent Developments
5.10 QIAGEN N.V.
5.10.1 QIAGEN N.V. Corporation Information
5.10.2 QIAGEN N.V. Description, Business Overview
5.10.3 QIAGEN N.V. Competent Cells Products Offered
5.10.4 QIAGEN N.V. Competent Cells Revenue and Gross Margin (2020-2025)
5.10.5 QIAGEN N.V. Competent Cells Revenue by Product in 2024
5.10.6 QIAGEN N.V. Competent Cells Revenue by Application in 2024
5.10.7 QIAGEN N.V. Competent Cells Revenue by Geographic Area in 2024
5.10.8 QIAGEN N.V. Recent Developments
5.11 OriGene Technologies
5.11.1 OriGene Technologies Corporation Information
5.11.2 OriGene Technologies Description, Business Overview
5.11.3 OriGene Technologies Competent Cells Products Offered
5.11.4 OriGene Technologies Competent Cells Revenue and Gross Margin (2020-2025)
5.11.5 OriGene Technologies Competent Cells Revenue by Product in 2024
5.11.6 OriGene Technologies Competent Cells Revenue by Application in 2024
5.11.7 OriGene Technologies Competent Cells Revenue by Geographic Area in 2024
5.11.8 OriGene Technologies Recent Developments
5.12 Lucigen
5.12.1 Lucigen Corporation Information
5.12.2 Lucigen Description, Business Overview
5.12.3 Lucigen Competent Cells Products Offered
5.12.4 Lucigen Competent Cells Revenue and Gross Margin (2020-2025)
5.12.5 Lucigen Competent Cells Revenue by Product in 2024
5.12.6 Lucigen Competent Cells Revenue by Application in 2024
5.12.7 Lucigen Competent Cells Revenue by Geographic Area in 2024
5.12.8 Lucigen Recent Developments
5.13 Zymo Research
5.13.1 Zymo Research Corporation Information
5.13.2 Zymo Research Description, Business Overview
5.13.3 Zymo Research Competent Cells Products Offered
5.13.4 Zymo Research Competent Cells Revenue and Gross Margin (2020-2025)
5.13.5 Zymo Research Competent Cells Revenue by Product in 2024
5.13.6 Zymo Research Competent Cells Revenue by Application in 2024
5.13.7 Zymo Research Competent Cells Revenue by Geographic Area in 2024
5.13.8 Zymo Research Recent Developments
5.14 Bio-Rad Laboratories
5.14.1 Bio-Rad Laboratories Corporation Information
5.14.2 Bio-Rad Laboratories Description, Business Overview
5.14.3 Bio-Rad Laboratories Competent Cells Products Offered
5.14.4 Bio-Rad Laboratories Competent Cells Revenue and Gross Margin (2020-2025)
5.14.5 Bio-Rad Laboratories Competent Cells Revenue by Product in 2024
5.14.6 Bio-Rad Laboratories Competent Cells Revenue by Application in 2024
5.14.7 Bio-Rad Laboratories Competent Cells Revenue by Geographic Area in 2024
5.14.8 Bio-Rad Laboratories Recent Developments
5.15 Bioline
5.15.1 Bioline Corporation Information
5.15.2 Bioline Description, Business Overview
5.15.3 Bioline Competent Cells Products Offered
5.15.4 Bioline Competent Cells Revenue and Gross Margin (2020-2025)
5.15.5 Bioline Competent Cells Revenue by Product in 2024
5.15.6 Bioline Competent Cells Revenue by Application in 2024
5.15.7 Bioline Competent Cells Revenue by Geographic Area in 2024
5.15.8 Bioline Recent Developments
5.16 Delphi Genetics
5.16.1 Delphi Genetics Corporation Information
5.16.2 Delphi Genetics Description, Business Overview
5.16.3 Delphi Genetics Competent Cells Products Offered
5.16.4 Delphi Genetics Competent Cells Revenue and Gross Margin (2020-2025)
5.16.5 Delphi Genetics Competent Cells Revenue by Product in 2024
5.16.6 Delphi Genetics Competent Cells Revenue by Application in 2024
5.16.7 Delphi Genetics Competent Cells Revenue by Geographic Area in 2024
5.16.8 Delphi Genetics Recent Developments
5.17 IBA GmBH
5.17.1 IBA GmBH Corporation Information
5.17.2 IBA GmBH Description, Business Overview
5.17.3 IBA GmBH Competent Cells Products Offered
5.17.4 IBA GmBH Competent Cells Revenue and Gross Margin (2020-2025)
5.17.5 IBA GmBH Competent Cells Revenue by Product in 2024
5.17.6 IBA GmBH Competent Cells Revenue by Application in 2024
5.17.7 IBA GmBH Competent Cells Revenue by Geographic Area in 2024
5.17.8 IBA GmBH Recent Developments
5.18 Cell Applications
5.18.1 Cell Applications Corporation Information
5.18.2 Cell Applications Description, Business Overview
5.18.3 Cell Applications Competent Cells Products Offered
5.18.4 Cell Applications Competent Cells Revenue and Gross Margin (2020-2025)
5.18.5 Cell Applications Competent Cells Revenue by Product in 2024
5.18.6 Cell Applications Competent Cells Revenue by Application in 2024
5.18.7 Cell Applications Competent Cells Revenue by Geographic Area in 2024
5.18.8 Cell Applications Recent Developments
5.19 BioDynamics Laboratory
5.19.1 BioDynamics Laboratory Corporation Information
5.19.2 BioDynamics Laboratory Description, Business Overview
5.19.3 BioDynamics Laboratory Competent Cells Products Offered
5.19.4 BioDynamics Laboratory Competent Cells Revenue and Gross Margin (2020-2025)
5.19.5 BioDynamics Laboratory Competent Cells Revenue by Product in 2024
5.19.6 BioDynamics Laboratory Competent Cells Revenue by Application in 2024
5.19.7 BioDynamics Laboratory Competent Cells Revenue by Geographic Area in 2024
5.19.8 BioDynamics Laboratory Recent Developments
5.20 Scarab Genomics
5.20.1 Scarab Genomics Corporation Information
5.20.2 Scarab Genomics Description, Business Overview
5.20.3 Scarab Genomics Competent Cells Products Offered
5.20.4 Scarab Genomics Competent Cells Revenue and Gross Margin (2020-2025)
5.20.5 Scarab Genomics Competent Cells Revenue by Product in 2024
5.20.6 Scarab Genomics Competent Cells Revenue by Application in 2024
5.20.7 Scarab Genomics Competent Cells Revenue by Geographic Area in 2024
5.20.8 Scarab Genomics Recent Developments
5.21 GCC Biotech
5.21.1 GCC Biotech Corporation Information
5.21.2 GCC Biotech Description, Business Overview
5.21.3 GCC Biotech Competent Cells Products Offered
5.21.4 GCC Biotech Competent Cells Revenue and Gross Margin (2020-2025)
5.21.5 GCC Biotech Competent Cells Revenue by Product in 2024
5.21.6 GCC Biotech Competent Cells Revenue by Application in 2024
5.21.7 GCC Biotech Competent Cells Revenue by Geographic Area in 2024
5.21.8 GCC Biotech Recent Developments
5.22 SMOBIO Technology
5.22.1 SMOBIO Technology Corporation Information
5.22.2 SMOBIO Technology Description, Business Overview
5.22.3 SMOBIO Technology Competent Cells Products Offered
5.22.4 SMOBIO Technology Competent Cells Revenue and Gross Margin (2020-2025)
5.22.5 SMOBIO Technology Competent Cells Revenue by Product in 2024
5.22.6 SMOBIO Technology Competent Cells Revenue by Application in 2024
5.22.7 SMOBIO Technology Competent Cells Revenue by Geographic Area in 2024
5.22.8 SMOBIO Technology Recent Developments
5.23 Edge BioSystems
5.23.1 Edge BioSystems Corporation Information
5.23.2 Edge BioSystems Description, Business Overview
5.23.3 Edge BioSystems Competent Cells Products Offered
5.23.4 Edge BioSystems Competent Cells Revenue and Gross Margin (2020-2025)
5.23.5 Edge BioSystems Competent Cells Revenue by Product in 2024
5.23.6 Edge BioSystems Competent Cells Revenue by Application in 2024
5.23.7 Edge BioSystems Competent Cells Revenue by Geographic Area in 2024
5.23.8 Edge BioSystems Recent Developments
6 North America
6.1 North America Competent Cells Market Size YoY Growth 2020-2031
6.2 North America Competent Cells Market Facts & Figures by Country (2020-2031)
6.3 North America Competent Cells Revenue by Type (2020-2025)
6.4 North America Competent Cells Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Competent Cells Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Competent Cells Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Competent Cells Revenue by Type (2020-2025)
7.4 Asia-Pacific Competent Cells Revenue by Application (2020-2025)
8 Europe
8.1 Europe Competent Cells Market Size YoY Growth 2020-2031
8.2 Europe Competent Cells Market Facts & Figures by Country (2020-2031)
8.3 Europe Competent Cells Revenue by Type (2020-2025)
8.4 Europe Competent Cells Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Competent Cells Market Size YoY Growth 2020-2031
9.2 Latin America Competent Cells Market Facts & Figures by Country (2020-2031)
9.3 Latin America Competent Cells Revenue by Type (2020-2025)
9.4 Latin America Competent Cells Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Competent Cells Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Competent Cells Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Competent Cells Revenue by Type (2020-2025)
10.4 Middle East and Africa Competent Cells Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Competent Cells Supply Chain Analysis
11.2 Competent Cells Key Raw Materials and Upstream Suppliers
11.3 Competent Cells Clients Analysis
11.4 Competent Cells Sales Channel and Sales Model Analysis
11.4.1 Competent Cells Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Competent Cells Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Competent Cells Distributors
12 Competent Cells Market Dynamics
12.1 Competent Cells Industry Trends
12.2 Competent Cells Market Drivers
12.3 Competent Cells Market Challenges
12.4 Competent Cells Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Competent Cells Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Competent Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Competent Cells Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Competent Cells Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Competent Cells Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Competent Cells Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Competent Cells Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Competent Cells Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Competent Cells Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Competent Cells Revenue by Company (2020-2025) & (US$ Million)
Table 11. Competent Cells Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Competent Cells Players by Revenue (US$ Million) in 2024
Table 13. Global Competent Cells Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
Table 15. Global Competent Cells Companies Headquarters
Table 16. Date of International Companies Enter into Competent Cells Market
Table 17. Global Competent Cells Companies Product & Service
Table 18. Global Competent Cells Mergers & Acquisitions, Expansion Plans
Table 19. Merck KGaA Corporation Information
Table 20. Merck KGaA Description and Business Overview
Table 21. Merck KGaA Competent Cells Product
Table 22. Merck KGaA Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Merck KGaA Revenue Proportion of Competent Cells by Product in 2024
Table 24. Merck KGaA Revenue Proportion of Competent Cells by Application in 2024
Table 25. Merck KGaA Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 26. Merck KGaA Recent Developments
Table 27. Thermo Fisher Scientific Corporation Information
Table 28. Thermo Fisher Scientific Description and Business Overview
Table 29. Thermo Fisher Scientific Competent Cells Product
Table 30. Thermo Fisher Scientific Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Thermo Fisher Scientific Revenue Proportion of Competent Cells by Product in 2024
Table 32. Thermo Fisher Scientific Revenue Proportion of Competent Cells by Application in 2024
Table 33. Thermo Fisher Scientific Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 34. Thermo Fisher Scientific Recent Developments
Table 35. Agilent Technologies Corporation Information
Table 36. Agilent Technologies Description and Business Overview
Table 37. Agilent Technologies Competent Cells Product
Table 38. Agilent Technologies Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Agilent Technologies Revenue Proportion of Competent Cells by Product in 2024
Table 40. Agilent Technologies Revenue Proportion of Competent Cells by Application in 2024
Table 41. Agilent Technologies Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 42. Agilent Technologies Recent Developments
Table 43. Takara Bio Corporation Information
Table 44. Takara Bio Description and Business Overview
Table 45. Takara Bio Competent Cells Product
Table 46. Takara Bio Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Takara Bio Revenue Proportion of Competent Cells by Product in 2024
Table 48. Takara Bio Revenue Proportion of Competent Cells by Application in 2024
Table 49. Takara Bio Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 50. Takara Bio Recent Developments
Table 51. Promega Corporation Corporation Information
Table 52. Promega Corporation Description and Business Overview
Table 53. Promega Corporation Competent Cells Product
Table 54. Promega Corporation Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Promega Corporation Revenue Proportion of Competent Cells by Product in 2024
Table 56. Promega Corporation Revenue Proportion of Competent Cells by Application in 2024
Table 57. Promega Corporation Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 58. Promega Corporation Recent Developments
Table 59. Beijing TransGen Biotech Corporation Information
Table 60. Beijing TransGen Biotech Description and Business Overview
Table 61. Beijing TransGen Biotech Competent Cells Product
Table 62. Beijing TransGen Biotech Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Beijing TransGen Biotech Revenue Proportion of Competent Cells by Product in 2024
Table 64. Beijing TransGen Biotech Revenue Proportion of Competent Cells by Application in 2024
Table 65. Beijing TransGen Biotech Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 66. Beijing TransGen Biotech Recent Developments
Table 67. GeneScript Corporation Corporation Information
Table 68. GeneScript Corporation Description and Business Overview
Table 69. GeneScript Corporation Competent Cells Product
Table 70. GeneScript Corporation Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. GeneScript Corporation Revenue Proportion of Competent Cells by Product in 2024
Table 72. GeneScript Corporation Revenue Proportion of Competent Cells by Application in 2024
Table 73. GeneScript Corporation Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 74. GeneScript Corporation Recent Developments
Table 75. Yeastern Biotech Corporation Information
Table 76. Yeastern Biotech Description and Business Overview
Table 77. Yeastern Biotech Competent Cells Product
Table 78. Yeastern Biotech Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Yeastern Biotech Revenue Proportion of Competent Cells by Product in 2024
Table 80. Yeastern Biotech Revenue Proportion of Competent Cells by Application in 2024
Table 81. Yeastern Biotech Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 82. Yeastern Biotech Recent Developments
Table 83. New England Biolabs Corporation Information
Table 84. New England Biolabs Description and Business Overview
Table 85. New England Biolabs Competent Cells Product
Table 86. New England Biolabs Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. New England Biolabs Revenue Proportion of Competent Cells by Product in 2024
Table 88. New England Biolabs Revenue Proportion of Competent Cells by Application in 2024
Table 89. New England Biolabs Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 90. New England Biolabs Recent Developments
Table 91. QIAGEN N.V. Corporation Information
Table 92. QIAGEN N.V. Description and Business Overview
Table 93. QIAGEN N.V. Competent Cells Product
Table 94. QIAGEN N.V. Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. QIAGEN N.V. Revenue Proportion of Competent Cells by Product in 2024
Table 96. QIAGEN N.V. Revenue Proportion of Competent Cells by Application in 2024
Table 97. QIAGEN N.V. Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 98. QIAGEN N.V. Recent Developments
Table 99. OriGene Technologies Corporation Information
Table 100. OriGene Technologies Description and Business Overview
Table 101. OriGene Technologies Competent Cells Product
Table 102. OriGene Technologies Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. OriGene Technologies Revenue Proportion of Competent Cells by Product in 2024
Table 104. OriGene Technologies Revenue Proportion of Competent Cells by Application in 2024
Table 105. OriGene Technologies Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 106. OriGene Technologies Recent Developments
Table 107. Lucigen Corporation Information
Table 108. Lucigen Description and Business Overview
Table 109. Lucigen Competent Cells Product
Table 110. Lucigen Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Lucigen Revenue Proportion of Competent Cells by Product in 2024
Table 112. Lucigen Revenue Proportion of Competent Cells by Application in 2024
Table 113. Lucigen Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 114. Lucigen Recent Developments
Table 115. Zymo Research Corporation Information
Table 116. Zymo Research Description and Business Overview
Table 117. Zymo Research Competent Cells Product
Table 118. Zymo Research Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Zymo Research Revenue Proportion of Competent Cells by Product in 2024
Table 120. Zymo Research Revenue Proportion of Competent Cells by Application in 2024
Table 121. Zymo Research Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 122. Zymo Research Recent Developments
Table 123. Bio-Rad Laboratories Corporation Information
Table 124. Bio-Rad Laboratories Description and Business Overview
Table 125. Bio-Rad Laboratories Competent Cells Product
Table 126. Bio-Rad Laboratories Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Bio-Rad Laboratories Revenue Proportion of Competent Cells by Product in 2024
Table 128. Bio-Rad Laboratories Revenue Proportion of Competent Cells by Application in 2024
Table 129. Bio-Rad Laboratories Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 130. Bio-Rad Laboratories Recent Developments
Table 131. Bioline Corporation Information
Table 132. Bioline Description and Business Overview
Table 133. Bioline Competent Cells Product
Table 134. Bioline Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Bioline Revenue Proportion of Competent Cells by Product in 2024
Table 136. Bioline Revenue Proportion of Competent Cells by Application in 2024
Table 137. Bioline Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 138. Bioline Recent Developments
Table 139. Delphi Genetics Corporation Information
Table 140. Delphi Genetics Description and Business Overview
Table 141. Delphi Genetics Competent Cells Product
Table 142. Delphi Genetics Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Delphi Genetics Revenue Proportion of Competent Cells by Product in 2024
Table 144. Delphi Genetics Revenue Proportion of Competent Cells by Application in 2024
Table 145. Delphi Genetics Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 146. Delphi Genetics Recent Developments
Table 147. IBA GmBH Corporation Information
Table 148. IBA GmBH Description and Business Overview
Table 149. IBA GmBH Competent Cells Product
Table 150. IBA GmBH Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. IBA GmBH Revenue Proportion of Competent Cells by Product in 2024
Table 152. IBA GmBH Revenue Proportion of Competent Cells by Application in 2024
Table 153. IBA GmBH Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 154. IBA GmBH Recent Developments
Table 155. Cell Applications Corporation Information
Table 156. Cell Applications Description and Business Overview
Table 157. Cell Applications Competent Cells Product
Table 158. Cell Applications Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Cell Applications Revenue Proportion of Competent Cells by Product in 2024
Table 160. Cell Applications Revenue Proportion of Competent Cells by Application in 2024
Table 161. Cell Applications Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 162. Cell Applications Recent Developments
Table 163. BioDynamics Laboratory Corporation Information
Table 164. BioDynamics Laboratory Description and Business Overview
Table 165. BioDynamics Laboratory Competent Cells Product
Table 166. BioDynamics Laboratory Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. BioDynamics Laboratory Revenue Proportion of Competent Cells by Product in 2024
Table 168. BioDynamics Laboratory Revenue Proportion of Competent Cells by Application in 2024
Table 169. BioDynamics Laboratory Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 170. BioDynamics Laboratory Recent Developments
Table 171. Scarab Genomics Corporation Information
Table 172. Scarab Genomics Description and Business Overview
Table 173. Scarab Genomics Competent Cells Product
Table 174. Scarab Genomics Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. Scarab Genomics Revenue Proportion of Competent Cells by Product in 2024
Table 176. Scarab Genomics Revenue Proportion of Competent Cells by Application in 2024
Table 177. Scarab Genomics Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 178. Scarab Genomics Recent Developments
Table 179. GCC Biotech Corporation Information
Table 180. GCC Biotech Description and Business Overview
Table 181. GCC Biotech Competent Cells Product
Table 182. GCC Biotech Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. GCC Biotech Revenue Proportion of Competent Cells by Product in 2024
Table 184. GCC Biotech Revenue Proportion of Competent Cells by Application in 2024
Table 185. GCC Biotech Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 186. GCC Biotech Recent Developments
Table 187. SMOBIO Technology Corporation Information
Table 188. SMOBIO Technology Description and Business Overview
Table 189. SMOBIO Technology Competent Cells Product
Table 190. SMOBIO Technology Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 191. SMOBIO Technology Revenue Proportion of Competent Cells by Product in 2024
Table 192. SMOBIO Technology Revenue Proportion of Competent Cells by Application in 2024
Table 193. SMOBIO Technology Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 194. SMOBIO Technology Recent Developments
Table 195. Edge BioSystems Corporation Information
Table 196. Edge BioSystems Description and Business Overview
Table 197. Edge BioSystems Competent Cells Product
Table 198. Edge BioSystems Competent Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 199. Edge BioSystems Revenue Proportion of Competent Cells by Product in 2024
Table 200. Edge BioSystems Revenue Proportion of Competent Cells by Application in 2024
Table 201. Edge BioSystems Revenue Proportion of Competent Cells by Geographic Area in 2024
Table 202. Edge BioSystems Recent Developments
Table 203. North America Competent Cells Revenue by Country (2020-2025) & (US$ Million)
Table 204. North America Competent Cells Revenue by Country (2026-2031) & (US$ Million)
Table 205. North America Competent Cells Revenue by Type (2020-2025) & (US$ Million)
Table 206. North America Competent Cells Revenue by Application (2020-2025) & (US$ Million)
Table 207. Asia-Pacific Competent Cells Revenue by Region (2020-2025) & (US$ Million)
Table 208. Asia-Pacific Competent Cells Revenue by Region (2026-2031) & (US$ Million)
Table 209. Asia-Pacific Competent Cells Revenue by Type (2020-2025) & (US$ Million)
Table 210. Asia-Pacific Competent Cells Revenue by Application (2020-2025) & (US$ Million)
Table 211. Europe Competent Cells Revenue by Country (2020-2025) & (US$ Million)
Table 212. Europe Competent Cells Revenue by Country (2026-2031) & (US$ Million)
Table 213. Europe Competent Cells Revenue by Type (2020-2025) & (US$ Million)
Table 214. Europe Competent Cells Revenue by Application (2020-2025) & (US$ Million)
Table 215. Latin America Competent Cells Revenue by Country (2020-2025) & (US$ Million)
Table 216. Latin America Competent Cells Revenue by Country (2026-2031) & (US$ Million)
Table 217. Latin America Competent Cells Revenue by Type (2020-2025) & (US$ Million)
Table 218. Latin America Competent Cells Revenue by Application (2020-2025) & (US$ Million)
Table 219. Middle East and Africa Competent Cells Revenue by Country (2020-2025) & (US$ Million)
Table 220. Middle East and Africa Competent Cells Revenue by Country (2026-2031) & (US$ Million)
Table 221. Middle East and Africa Competent Cells Revenue by Type (2020-2025) & (US$ Million)
Table 222. Middle East and Africa Competent Cells Revenue by Application (2020-2025) & (US$ Million)
Table 223. Competent Cells Key Raw Materials, Industry Status and Trend
Table 224. Competent Cells Key Raw Materials and Upstream Suppliers
Table 225. Competent Cells Clients Status and Trend
Table 226. Competent Cells Typical Clients
Table 227. Competent Cells Distributors
Table 228. Competent Cells Market Trends
Table 229. Competent Cells Market Drivers
Table 230. Competent Cells Market Challenges
Table 231. Competent Cells Market Restraints
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Competent Cells Product Picture
Figure 2. Global Competent Cells Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Competent Cells Revenue Market Share by Type in 2024 & 2031
Figure 4. Chemically Competent Cells Product Picture
Figure 5. Electrocompetent Cells Product Picture
Figure 6. Global Competent Cells Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Competent Cells Revenue Market Share by Application in 2024 & 2031
Figure 8. Subcloning & Routine Cloning
Figure 9. Phage Display Library Construction
Figure 10. Toxic/Unstable DNA Cloning
Figure 11. High-Throughput Cloning
Figure 12. Protein Expression
Figure 13. Mutagenesis
Figure 14. Single-Stranded DNA Production
Figure 15. Bacmid Creation
Figure 16. Cre-Lox Recombination (PIR1/PIR2)
Figure 17. Competent Cells Report Years Considered
Figure 18. Global Competent Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Competent Cells Market Size (2020-2031) & (US$ Million)
Figure 20. Global Competent Cells Market Size Market Share by Region: 2024 Versus 2031
Figure 21. Global Competent Cells Revenue Market Share by Region (2020-2031)
Figure 22. Global Competent Cells Revenue Market Share Forecast by Type (2020-2031)
Figure 23. Global Competent Cells Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Chemically Competent Cells of Competent Cells Revenue Market Share by Application, 2024 VS 2031
Figure 25. Electrocompetent Cells of Competent Cells Revenue Market Share by Application, 2024 VS 2031
Figure 26. Competent Cells Revenue Share by Company (2024)
Figure 27. Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Chemically Competent Cells Revenue Proportion by Company in 2024
Figure 29. Electrocompetent Cells Revenue Proportion by Company in 2024
Figure 30. North America Competent Cells Revenue 2020-2031 (US$ Million)
Figure 31. North America Competent Cells Revenue Market Share by Type (2020-2025)
Figure 32. North America Competent Cells Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Competent Cells Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Competent Cells Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Competent Cells Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Competent Cells Revenue Market Share by Application (2020-2025)
Figure 37. Europe Competent Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Competent Cells Revenue Market Share by Country (2020-2031)
Figure 39. Europe Competent Cells Revenue Market Share by Type (2020-2025)
Figure 40. Europe Competent Cells Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Competent Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Competent Cells Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Competent Cells Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Competent Cells Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Competent Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Competent Cells Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Competent Cells Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Competent Cells Revenue Market Share by Application (2020-2025)
Figure 49. Competent Cells Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Competent Cells Raw Materials by Region in 2024
Figure 51. Competent Cells Distribution Channels
Figure 52. Global Competent Cells Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Competent Cells Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
